<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref90">
 <mixed-citation publication-type="journal" id="cit90">
  <name>
   <surname>Brangel</surname>
   <given-names>P.</given-names>
  </name>; 
  <name>
   <surname>Sobarzo</surname>
   <given-names>A.</given-names>
  </name>; 
  <name>
   <surname>Parolo</surname>
   <given-names>C.</given-names>
  </name>; 
  <name>
   <surname>Miller</surname>
   <given-names>B. S.</given-names>
  </name>; 
  <name>
   <surname>Howes</surname>
   <given-names>P. D.</given-names>
  </name>; 
  <name>
   <surname>Gelkop</surname>
   <given-names>S.</given-names>
  </name>; 
  <name>
   <surname>Lutwama</surname>
   <given-names>J. J.</given-names>
  </name>; 
  <name>
   <surname>Dye</surname>
   <given-names>J. M.</given-names>
  </name>; 
  <name>
   <surname>McKendry</surname>
   <given-names>R. A.</given-names>
  </name>; 
  <name>
   <surname>Lobel</surname>
   <given-names>L.</given-names>
  </name>; et al. 
  <article-title>A Serological Point-of-Care Test for the Detection of IgG Antibodies against Ebola Virus in Human Survivors</article-title>. 
  <source>ACS Nano</source>
  <year>2018</year>, 
  <volume>12</volume> (
  <issue>1</issue>), 
  <fpage>63</fpage>â€“
  <lpage>73</lpage>. 
  <pub-id pub-id-type="doi">10.1021/acsnano.7b07021</pub-id>.
  <pub-id pub-id-type="pmid">29303554</pub-id>
 </mixed-citation>
</ref>
